Variant report
Variant | nsv981105 |
---|---|
Chromosome Location | chr6:12319682-12320423 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:12320054..12322576-chr6:12323490..12326394,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SUMO2P12 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16872650 | chr6:12319683-12319684 | Weak transcription ZNF genes & repeats Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs532068788 | chr6:12319691-12319692 | Weak transcription ZNF genes & repeats Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576140341 | chr6:12319692-12319693 | Weak transcription ZNF genes & repeats Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79131302 | chr6:12319720-12319721 | Weak transcription ZNF genes & repeats Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565156233 | chr6:12319724-12319725 | Weak transcription ZNF genes & repeats Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371370510 | chr6:12319727-12319728 | Weak transcription ZNF genes & repeats Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188028237 | chr6:12319739-12319740 | Weak transcription ZNF genes & repeats Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541178474 | chr6:12319749-12319750 | Weak transcription ZNF genes & repeats Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs151325323 | chr6:12319761-12319762 | Weak transcription ZNF genes & repeats Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569451466 | chr6:12319805-12319806 | Weak transcription Strong transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140095954 | chr6:12319819-12319820 | Weak transcription Strong transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538464351 | chr6:12319845-12319846 | Weak transcription Strong transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549892818 | chr6:12319855-12319856 | Weak transcription Strong transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150286273 | chr6:12319884-12319885 | Weak transcription Strong transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs137990386 | chr6:12319934-12319935 | Weak transcription Strong transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552175885 | chr6:12319986-12319987 | Weak transcription Strong transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566318011 | chr6:12320013-12320014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192700208 | chr6:12320021-12320022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149051392 | chr6:12320043-12320044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554730647 | chr6:12320094-12320095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376528073 | chr6:12320105-12320106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115621100 | chr6:12320135-12320136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185000831 | chr6:12320188-12320189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200607828 | chr6:12320204-12320205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187470234 | chr6:12320211-12320212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145582526 | chr6:12320221-12320222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs80316794 | chr6:12320256-12320257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12200712 | chr6:12320276-12320277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs145845910 | chr6:12320277-12320278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558275620 | chr6:12320281-12320282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370132733 | chr6:12320319-12320320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9462666 | chr6:12320327-12320328 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs561905561 | chr6:12320351-12320352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561117335 | chr6:12320355-12320356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576876084 | chr6:12320376-12320377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs202245346 | chr6:12320380-12320381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369311020 | chr6:12320381-12320382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200297996 | chr6:12320388-12320389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78482247 | chr6:12320389-12320390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs4711655 | chr6:12320393-12320394 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 21183584 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:12315200-12327800 | Weak transcription | Placenta Amnion | Placenta Amnion |
2 | chr6:12317600-12320000 | ZNF genes & repeats | A549 | lung |
3 | chr6:12319000-12319800 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr6:12319000-12320000 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr6:12319200-12324600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr6:12319400-12320200 | Enhancers | GM12878-XiMat | blood |
7 | chr6:12319400-12324200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr6:12319400-12324400 | Weak transcription | H1 Cell Line | embryonic stem cell |
9 | chr6:12319400-12324400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr6:12319400-12325600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr6:12319600-12324400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr6:12319800-12324400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr6:12320000-12321200 | Weak transcription | A549 | lung |
14 | chr6:12320000-12324800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |